Distinguished in Myasthenia Gravis

Dr. Kumaraswamy Sivakumar

Neurology
SNY Corp. Inc.
4545 E Shea Blvd Ste 175, 
Phoenix, AZ 
Offers Telehealth

Distinguished in Myasthenia Gravis
SNY Corp. Inc.
4545 E Shea Blvd Ste 175, 
Phoenix, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kumaraswamy Sivakumar is a Neurologist in Phoenix, Arizona. Dr. Sivakumar is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Inclusion Body Myositis, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, and Pompe Disease.

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Myasthenia Gravis.

Specialties
Neurology
Licenses
Specialist in AZ
Hospital Affiliations
St Josephs Hospital And Medical Center
Yavapai Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EMI Health
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

SNY Corp. Inc.
4545 E Shea Blvd Ste 175, Phoenix, AZ 85028
Call: 480-314-1007

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: November 18, 2025
Intervention Type: Drug
Study Drugs: SRP-4045 Exon 45-Skipping Treatment, SRP-4053 Exon 53-Skipping Treatment
Study Phase: Phase 3
An Open-Label, Fixed-Sequence, Ascending-Dose, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous Infusions of ATB200 Co-Administered With Oral AT2221 in Adult Subjects With Pompe Disease
An Open-Label, Fixed-Sequence, Ascending-Dose, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous Infusions of ATB200 Co-Administered With Oral AT2221 in Adult Subjects With Pompe Disease
Enrollment Status: Completed
Publish Date: October 23, 2025
Intervention Type: Drug
Study Drugs: ATB200, AT2221
Study Phase: Phase 1/Phase 2
A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2025
Intervention Type: Drug
Study Drug: Fasudil (WP-0512)
Study Phase: Phase 2
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Biological
Study Drug: HYQVIA
Study Phase: Phase 3
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Enrollment Status: Terminated
Publish Date: June 14, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

14 Total Publications

Correction: Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02).
Correction: Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02).
Journal: Journal of neurology
Published: February 17, 2025
View All 14 Publications
Similar Doctors
Distinguished in Myasthenia Gravis
Dr. Suraj Muley
Neurology
Distinguished in Myasthenia Gravis
Dr. Suraj Muley
Neurology

Office

7242 E Osborn Rd Ste 400, 
Scottsdale, AZ 
 (17.0 miles away)
602-258-3354
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Suraj Muley is a Neurologist in Scottsdale, Arizona. Dr. Muley is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Multifocal Motor Neuropathy, and Chronic Polyradiculoneuritis.

Distinguished in Myasthenia Gravis
Dr. Todd D. Levine
Neurology
Distinguished in Myasthenia Gravis
Dr. Todd D. Levine
Neurology

HonorHealth Neurology - Bob Bové Neuroscience Institute

7242 E. Osborn Rd, Suite 400, 
Scottsdale, AZ 
 (17.0 miles away)
602-258-3354
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Todd Levine is a Neurologist in Scottsdale, Arizona. Dr. Levine is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Inclusion Body Myositis, Myasthenia Gravis, and Spinal and Bulbar Muscular Atrophy. Dr. Levine is currently accepting new patients.

Distinguished in Myasthenia Gravis
Dr. Erik L. Ortega
Neurology
Distinguished in Myasthenia Gravis
Dr. Erik L. Ortega
Neurology

Sjhmc Physician Services

500 W Thomas Rd, 680 Dhmg St Joseph's Pelvi, 
Phoenix, AZ 
 (10.5 miles away)
602-406-6017
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Erik Ortega is a Neurologist in Phoenix, Arizona. Dr. Ortega is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myasthenia Gravis, Chronic Polyradiculoneuritis, Dysferlinopathy, and Guillain-Barre Syndrome. Dr. Ortega is currently accepting new patients.

VIEW MORE MYASTHENIA GRAVIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sivakumar's expertise for a condition
ConditionClose
  • Elite
  • Inclusion Body Myositis
    Dr. Sivakumar is
    Elite
    . Learn about Inclusion Body Myositis.
    See more Inclusion Body Myositis experts
  • Distinguished
  • Adult Polyglucosan Body Disease
    Dr. Sivakumar is
    Distinguished
    . Learn about Adult Polyglucosan Body Disease.
    See more Adult Polyglucosan Body Disease experts
  • Andersen Disease
    Dr. Sivakumar is
    Distinguished
    . Learn about Andersen Disease.
    See more Andersen Disease experts
  • Chronic Inflammatory Demyelinating Polyneuropathy
    Dr. Sivakumar is
    Distinguished
    . Learn about Chronic Inflammatory Demyelinating Polyneuropathy.
    See more Chronic Inflammatory Demyelinating Polyneuropathy experts
  • Cramp-Fasciculation Syndrome
    Dr. Sivakumar is
    Distinguished
    . Learn about Cramp-Fasciculation Syndrome.
    See more Cramp-Fasciculation Syndrome experts
  • Dermatomyositis
    Dr. Sivakumar is
    Distinguished
    . Learn about Dermatomyositis.
    See more Dermatomyositis experts
  • Glycogen Storage Disease Type 0
    Dr. Sivakumar is
    Distinguished
    . Learn about Glycogen Storage Disease Type 0.
    See more Glycogen Storage Disease Type 0 experts
View All 15 Distinguished Conditions
  • Advanced
  • Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
    Dr. Sivakumar is
    Advanced
    . Learn about Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).
    See more Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) experts
  • Andermann Syndrome
    Dr. Sivakumar is
    Advanced
    . Learn about Andermann Syndrome.
    See more Andermann Syndrome experts
  • Andersen-Tawil Syndrome
    Dr. Sivakumar is
    Advanced
    . Learn about Andersen-Tawil Syndrome.
    See more Andersen-Tawil Syndrome experts
  • Becker Muscular Dystrophy
    Dr. Sivakumar is
    Advanced
    . Learn about Becker Muscular Dystrophy.
    See more Becker Muscular Dystrophy experts
  • Charcot-Marie-Tooth Disease
    Dr. Sivakumar is
    Advanced
    . Learn about Charcot-Marie-Tooth Disease.
    See more Charcot-Marie-Tooth Disease experts
  • Chronic Polyradiculoneuritis
    Dr. Sivakumar is
    Advanced
    . Learn about Chronic Polyradiculoneuritis.
    See more Chronic Polyradiculoneuritis experts
View All 57 Advanced Conditions
  • Experienced
  • Bell's Palsy
    Dr. Sivakumar is
    Experienced
    . Learn about Bell's Palsy.
    See more Bell's Palsy experts
  • Brachial Plexopathy
    Dr. Sivakumar is
    Experienced
    . Learn about Brachial Plexopathy.
    See more Brachial Plexopathy experts
  • Cervical Myelopathy
    Dr. Sivakumar is
    Experienced
    . Learn about Cervical Myelopathy.
    See more Cervical Myelopathy experts
  • Chronic Demyelinizing Neuropathy with IgM Monoclonal
    Dr. Sivakumar is
    Experienced
    . Learn about Chronic Demyelinizing Neuropathy with IgM Monoclonal.
    See more Chronic Demyelinizing Neuropathy with IgM Monoclonal experts
  • Cluster Headache
    Dr. Sivakumar is
    Experienced
    . Learn about Cluster Headache.
    See more Cluster Headache experts
  • Common Peroneal Nerve Dysfunction
    Dr. Sivakumar is
    Experienced
    . Learn about Common Peroneal Nerve Dysfunction.
    See more Common Peroneal Nerve Dysfunction experts
View All 48 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.